BACKGROUND AND PURPOSE: Vascular tolerance to nitroglycerin (GTN) may be caused by impaired GTN bioactivation due to inactivation of mitochondrial aldehyde dehydrogenase (ALDH2). As relaxation to GTN is reduced but still sensitive to ALDH2 inhibitors in ascorbate deficiency, we compared the contribution of ALDH2 inactivation to GTN hyposensitivity in ascorbate deficiency and classical in vivo nitrate tolerance. EXPERIMENTAL APPROACH: Guinea pigs were fed standard or ascorbate-free diet for 2 weeks. Reversibility was tested by feeding ascorbate-deficient animals standard diet for 1 week. Nitrate tolerance was induced by subcutaneous injection of 50 mg x kg(-1) GTN 4 times daily for 3 days. Ascorbate levels were determined in plasma, blood vessels, heart and liver. GTN-induced relaxation was measured as isometric tension of aortic rings; vascular GTN biotransformation was assayed as formation of 1,2- and 1,3-glyceryl dinitrate (GDN). KEY RESULTS: Two weeks of ascorbate deprivation had no effect on relaxation to nitric oxide but reduced the potency of GTN approximately 10-fold in a fully reversible manner. GTN-induced relaxation was similarly reduced in nitrate tolerance but not further attenuated by ALDH inhibitors. Nitrate tolerance reduced ascorbate plasma levels without affecting ascorbate in blood vessels, liver and heart. GTN denitration was significantly diminished in nitrate-tolerant and ascorbate-deficient rings. However, while the approximately 10-fold preferential 1,2-GDN formation, indicative for active ALDH2, had been retained in ascorbate deficiency, selectivity was largely lost in nitrate tolerance. CONCLUSIONS AND IMPLICATIONS: These results indicate that nitrate tolerance is associated with ALDH2 inactivation, whereas ascorbate deficiency possibly results in down-regulation of ALDH2 expression.
BACKGROUND AND PURPOSE: Vascular tolerance to nitroglycerin (GTN) may be caused by impaired GTN bioactivation due to inactivation of mitochondrial aldehyde dehydrogenase (ALDH2). As relaxation to GTN is reduced but still sensitive to ALDH2 inhibitors in ascorbatedeficiency, we compared the contribution of ALDH2 inactivation to GTN hyposensitivity in ascorbatedeficiency and classical in vivo nitrate tolerance. EXPERIMENTAL APPROACH: Guinea pigs were fed standard or ascorbate-free diet for 2 weeks. Reversibility was tested by feeding ascorbate-deficient animals standard diet for 1 week. Nitrate tolerance was induced by subcutaneous injection of 50 mg x kg(-1) GTN 4 times daily for 3 days. Ascorbate levels were determined in plasma, blood vessels, heart and liver. GTN-induced relaxation was measured as isometric tension of aortic rings; vascular GTN biotransformation was assayed as formation of 1,2- and 1,3-glyceryl dinitrate (GDN). KEY RESULTS: Two weeks of ascorbate deprivation had no effect on relaxation to nitric oxide but reduced the potency of GTN approximately 10-fold in a fully reversible manner. GTN-induced relaxation was similarly reduced in nitrate tolerance but not further attenuated by ALDH inhibitors. Nitrate tolerance reduced ascorbate plasma levels without affecting ascorbate in blood vessels, liver and heart. GTN denitration was significantly diminished in nitrate-tolerant and ascorbate-deficient rings. However, while the approximately 10-fold preferential 1,2-GDN formation, indicative for active ALDH2, had been retained in ascorbatedeficiency, selectivity was largely lost in nitrate tolerance. CONCLUSIONS AND IMPLICATIONS: These results indicate that nitrate tolerance is associated with ALDH2 inactivation, whereas ascorbatedeficiency possibly results in down-regulation of ALDH2 expression.
Authors: P Wenzel; U Hink; M Oelze; A Seeling; T Isse; K Bruns; L Steinhoff; M Brandt; A L Kleschyov; E Schulz; K Lange; H Weiner; J Lehmann; K J Lackner; T Kawamoto; T Münzel; A Daiber Journal: Br J Pharmacol Date: 2007-01-15 Impact factor: 8.739
Authors: Juan V Esplugues; Milagros Rocha; Cristina Nuñez; Irene Bosca; Sales Ibiza; Jose R Herance; Angel Ortega; Juan M Serrador; Pilar D'Ocon; Victor M Victor Journal: Circ Res Date: 2006-10-19 Impact factor: 17.367
Authors: Isla S Mackenzie; Kaisa M Maki-Petaja; Carmel M McEniery; Yi Ping Bao; Sharon M Wallace; Joseph Cheriyan; Sue Monteith; Morris J Brown; Ian B Wilkinson Journal: Arterioscler Thromb Vasc Biol Date: 2005-07-28 Impact factor: 8.311
Authors: Kelly K Parsons; Nobuyo Maeda; Mitsuo Yamauchi; Albert J Banes; Beverly H Koller Journal: Am J Physiol Endocrinol Metab Date: 2005-12-13 Impact factor: 4.310
Authors: Philip Wenzel; Ulrich Hink; Matthias Oelze; Swaantje Schuppan; Karin Schaeuble; Stefan Schildknecht; Kwok K Ho; Henry Weiner; Markus Bachschmid; Thomas Münzel; Andreas Daiber Journal: J Biol Chem Date: 2006-11-13 Impact factor: 5.157
Authors: Cristina Núñez; Víctor M Víctor; Remedios Tur; Alberto Alvarez-Barrientos; Salvador Moncada; Juan V Esplugues; Pilar D'Ocón Journal: Circ Res Date: 2005-10-13 Impact factor: 17.367
Authors: Zhiqiang Chen; Matthew W Foster; Jian Zhang; Lan Mao; Howard A Rockman; Toshihiro Kawamoto; Kyoko Kitagawa; Keiichi I Nakayama; Douglas T Hess; Jonathan S Stamler Journal: Proc Natl Acad Sci U S A Date: 2005-08-15 Impact factor: 11.205
Authors: Elizabeth Rose Axton; Eleonso Cristobal; Jaewoo Choi; Cristobal L Miranda; Jan Frederik Stevens Journal: Front Pharmacol Date: 2018-09-25 Impact factor: 5.810
Authors: Matteo Beretta; Antonius C F Gorren; M Verena Wenzl; Robert Weis; Michael Russwurm; Doris Koesling; Kurt Schmidt; Bernd Mayer Journal: J Biol Chem Date: 2009-11-11 Impact factor: 5.157
Authors: G Wölkart; M Beretta; M V Wenzl; H Stessel; K Schmidt; N Maeda; B Mayer; A Schrammel Journal: Br J Pharmacol Date: 2013-04 Impact factor: 8.739